A general overview of burn care

International Wound Journal

Volumn 2, Issue 3, 2005, Pages 206-220

  Hermans, Michel H E ^a,b  

^a Hermans Consulting Inc   (United States)

^b NONE   (United States)

Author keywords

Burn disease; Burn wound; Burn wound management; General burn care

Indexed keywords

BURN; CHEMICAL BURN; DISEASE CLASSIFICATION; DISEASE SEVERITY; DONOR SITE; ELECTRIC BURN; EPIDERMOLYSIS BULLOSA; FIRST AID; FLUSHING; LONG TERM CARE; LUNG BURN; MEDICAL PERSONNEL; NECROTIZING FASCIITIS; PHAEOHYPHOMYCOSIS; PRIORITY JOURNAL; REVIEW; SCALD; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; WOUND CARE; WOUND DRESSING;

EID: 28444466602     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-4801.2005.00129.x     Document Type: Review

References (177)

1. Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: a comprehensive review [see comments]. Plast Reconstr Surg 1989;84(5): 827-37.
2. DeToledo JC, Lowe MR. Microwave oven injuries in patients with complex partial seizures. Epilepsy Behav 2004;5(5):772-4.
3. Josty IC, Mason WT, Dickson WA. Burn wound management in patients with epilepsy: adopting a multidisciplinary approach. J Wound Care 2002;11(1):31-4.
4. Sances A Jr, Myklebust JB, Larson SJ, Darin JC, Swiontek T, Prieto T, Chilbert M, Cusick JF. Experimental electrical injury studies. J Trauma 1981;21(8):589-97.
5. Sykes RA, Mani MM, Hiebert JM. Chemical burns: retrospective review. J Burn Care Rehabil 1986;7(4):343-7.
6. Pulla RJ, Pickard LJ, Carnett TS. Frostbite: an overview with case presentations. J Foot Ankle Surg 1994;33(1):53-63.
7. Peters W, Zaidi J, Douglas L. Toxic epidermal necrolysis: a burn-centre challenge. Cmaj 1991; 144(11):1477-80.
8. Kelemen JJ III, Cioffi WG, McManus WF, Mason AD Jr, Pruitt BA Jr. Burn center care for patients with toxic epidermal necrolysis. J Am Coll Surg 1995;180(3):273-8.
9. Spies M, Vogt PM, Herndon DN. [Toxic epidermal necrolysis. A case for the burn intensive care unit]. Chirurg 2003;74(5):452-60.
10. McGee T, Munster A. Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center. Plast Reconstr Surg 1998;102(4):1018-22.
11. Yarbrough DR III. Treatment of toxic epidermal necrolysis in a burn center. J S C Med Assoc 1997;93(9):347-50.
12. Redman DP, Friedman B, Law E, Still JM. Experience with necrotizing fasciitis at a burn care center. South Med J 2003;96(9):868-70.
13. Barillo DJ, McManus AT, Cancio LC, Sofer A, Goodwin CW. Burn center management of necrotizing fasciitis. J Burn Care Rehabil 2003;24(3):127-32.
14. Arnoldo BD, Purdue GF, Tchorz K, Hunt JL. A case report of phaeohyphomycosis caused by cladophialophora bantiana treated in a burn unit. J Burn Care Rehabil 2005;26(3):285-7.
15. Black KS, Hewitt CW, Miller DM, Ramos E, Halloran J, Bressler V, Martinez SE, Achauer BM. Burn depth evaluation with fluorometry: is it really definitive? J Burn Care Rehabil 1986;7(4):313-7.
16. Wachtel TL, Leopold GR, Frank HA, Frank DH. B-mode ultrasonic echo determination of depth of thermal injury. Burns Incl Therm Inj 1986;12(6):432-7.
17. Park DH, Hwang JW, Jang KS, Han DG, Ahn KY, Baik BS. Use of laser Doppler flowmetry for estimation of the depth of burns. Plast Reconstr Surg 1998;101(6):1516-23.
18. Holland AJ, Martin HC, Cass DT. Laser Doppler imaging prediction of burn wound outcome in children. Burns 2002;28(1):11-7.
19. Hemington-Gorse SJ. A comparison of laser Doppler imaging with other measurement techniques to assess burn depth. J Wound Care 2005;14(4):151-3.
20. Mileski WJ, Atiles L, Purdue G, Kagan R, Saffle JR, Herndon DN, Heimbach D, Luterman A, Yurt R, Goodwin C, Hunt JL. Serial measurements increase the accuracy of laser Doppler assessment of burn wounds. J Burn Care Rehabil 2003;24(4):187-91.
21. Riordan CL, McDonough M, Davidson JM, Corley R, Perlov C, Barton R, Guy J, Nanney LB. Noncontact laser Doppler imaging in burn depth analysis of the extremities. J Burn Care Rehabil 2003;24(4):177-86.
22. Saranto JR, Rubayi S, Zawacki BE. Blisters, cooling, antithromboxanes, and healing in experimental zone-of-stasis burns. J Trauma 1983;23(10):927-33.
23. Zawacki BE. The natural history of reversible burn injury. Surg Gynecol Obstet 1974;139(6):867-72.
24. Zawacki BE. Reversal of capillary stasis and prevention of necrosis in burns. Ann Surg 1974;180(1):98-102.
25. Hermans MHE. Treatment of burns with occlusive dressings: some pathophysiological and quality of life aspects. Burns 1992;18 Suppl 2:515-8.
26. Herndon DN. Total Burn Care, 2nd edition. New York: Saunders, 2002.
27. Lund CC, Browder NC. The estimate of area of burns. Surg Gynecol Obstet 1944;79:352-8.
28. Rosenthal SR. Burn toxin and its competitin. Burns Incl Therm Inj 1982;8(3):215-9.
29. Allgower M, Stadtler K, Schoenenberger GA. Burn sepsis and burn toxin. Ann R Coll Surg Engl 1974;55(5):226-35.
30. Enkhbaatar P, Traber DL. Pathophysiology of acute lung injury in combined burn and smoke inhalation injury. Clin Sci (Lond) 2004;107(2): 137-43.
31. Smith DL, Cairns BA, Ramadan F, Dalston JS, Fakhry SM, Rutledge R, Meyer AA, Peterson HD. Effect of inhalation injury, burn size, and age on mortality: a study of 1447 consecutive burn patients. J Trauma 1994;37(4):655-9.
32. Barrow RE, Spies M, Barrow LN, Herndon DN. Influence of demographics and inhalation injury on burn mortality in children. Burns 2004;30(1): 72-7.
33. Herndon DN, Gore D, Cole M, Desai MH, Linares H, Abston S, Rutan T, Van Osten T, Barrow RE. Determinants of mortality in pediatric patients with greater than 70% full-thickness total body surface area thermal injury treated by early total excision and grafting. J Trauma 1987;27(2): 208-12.
34. Herndon DN, LeMaster J, Beard S, Bernstein N, Lewis SR, Rutan TC, Winkler JB, Cole M, Bjarnason D, Gore D. The quality of life after major thermal injury in children: an analysis of 12 survivors with greater than or equal to 80% total body, 70% third-degree burns. J Trauma 1986;26(7):609-19.
35. Moritz ARH, Henriquez FC. Studies of thermal injury. The relative importance of time and surface area in the causation of cutaneous burns. Am J Pathol 1947;23:695-720.
36. King TC, Zimmerman JM. First-aid cooling of the fresh burn. Surg Gynecol Obstet 1965;120:1271-3.
37. King TC, Zimmerman JM. Optimum temperatures for postburn cooling. Arch Surg 1965;91(4): 656-7.
38. King TC, Zimmerman JM, Price PB. Effect of immediate short-term cooling on extensive burns. Surg Forum 1962;13:487-8.
39. Demling RH, Mazess RB, Wolberg W. The effect of immediate and delayed cold immersion on burn edema formation and resorption. J Trauma 1979;19(1):56-60.
40. Demling RH. Burns. N Engl J Med 1985;313(22): 1389-98.
41. Stratta RJ, Saffle JR, Kravitz M, Warden GD. Management of tar and asphalt injuries. Am J Surg 1983;146(6):766-9.
42. Leonard LG, Scheulen JJ, Munster AM. Chemical burns: effect of prompt first aid. J Trauma 1982;22(5):420-3.
43. Hermans MHE, Vloemans AFPM. [A patient with a subungual burn caused by hydrofluoric acid]. Ned Tijdschr Geneeskd 1985;129(52):2510-1.
44. Eldad A, Chaouat M, Weinberg A, Neuman A, Ben Meir P, Rotem M. Phosphorous pentachloride chemical burn - a slowly healing injury. Burns 1992;18(4):340-1.
45. Eldad A, Simon GA. The phosphorous burn - a preliminary comparative experimental study of various forms of treatment. Burns 1991;17(3): 198-200.
46. Iverson RE, Laub DR. Hydrofluoric acid burn therapy. Surg Forum 1970;21:517-9.
47. Murao M. Studies on the treatment of hydrofluoric acid burn. Bull Osaka Med Coll 1989;35(1-2): 39-48.
48. Mangion SM, Beulke SH, Braitberg G. Hydrofluoric acid burn from a household rust remover. Med J Aust 2001;175(5):270-1.
49. ABA. Advanced Life Support Providers Manual. Chicago, IL: American Burn Association, 1994.
50. Pegg SP. Escharotomy in burns. Ann Acad Med Singapore 1992;21(5):682-4.
51. Wong L, Spence RJ. Escharotomy and fasciotomy of the burned upper extremity. Hand Clin 2000; 16(2):165-74, vii.
52. Tsoutsos D, Rodopoulou S, Keramidas E, Lagios M, Stamatopoulos K, Ioannovich J. Early escharotomy as a measure to reduce intraabdominal hypertension in full-thickness burns of the thoracic and abdominal area. World J Surg 2003; 27(12):1323-8.
53. Hansbrough JF, Achauer B, Dawson J, Himel H, Luterman A, Slater H, Levenson S, Salzberg CA, Hansbrough WB, Dore C. Wound healing in partial-thickness burn wounds treated with collagenase ointment versus silver sulfadiazine cream. J Burn Care Rehabil 1995;16(3 pt 1):241-7.
54. Ozcan C, Ergun O, Celik A, Corduk N, Ozok G. Enzymatic debridement of burn wound with collagenase in children with partial-thickness burns. Burns 2002;28(8):791-4.
55. Wilson AM, McGrouther DA, Eastwood M, Brown RA. The effect of burn blister fluid on fibroblast contraction. Burns 1997;23(4):306-12.
56. Uchinuma E, Koganei Y, Shioya JM, Yoshizato K. Biological evaluation of burn blister fluid. Ann Plast Surg 1988;20(3):225-30.
57. Swain AH, Azadian BS, Wakeley CJ, Shakespeare PG. Management of blisters in minor burns. Br Med J (Clin Res Ed) 1987;295(6591):181.
58. Rockwell WB, Ehrlich HP. Fibrinolysis inhibition in human burn blister fluid, J Burn Care Rehabil 1990;11(1):1-6.
59. Rockwell WB, Ehrlich HP. Should burn blister fluid be evacuated? J Burn Care Rehabil 1990;11(1):93-5.
60. Reagan BJ, Staiano-Coico L, LaBruna A, Mathwich M, Finkelstein J, Yurt RW, Goodwin CW, Madden MR. The effects of burn blister fluid on cultured keratinocytes. J Trauma 1996;40(3):361-7.
61. Ortega MR, Ganz T, Milner SM. Human beta defensin is absent in burn blister fluid. Burns 2000;26(8):724-6.
62. Ono I, Gunji H, Zhang JZ, Maruyama K, Kaneko F. A study of cytokines in burn blister fluid related to wound healing. Burns 1995;21(5):352-5.
63. Garner WL, Zuccaro C, Marcelo C, Rodriguez JL, Smith DJ Jr. The effects of burn blister fluid on keratinocyte replication and differentiation. J Burn Care Rehabil 1993;14(2 pt 1):127-31.
64. Deitch EA, Smith BJ. The effect of blister fluid from thermally injured patients on normal lymphocyte transformation. J Trauma 1983;23(2):106-10.
65. Deitch EA, Gelder F, McDonald JC. Biologic effect of blister fluid from thermal injuries on peripheral neutrophil chemotaxis. J Trauma 1982;22(2): 129-33.
66. Janzekovic Z. Early surgical treatment of the burned surface. Panminerva Med 1972;14(7-8): 228-32.
67. Janzekovic Z. The burn wound from the surgical point of view. J Trauma 1975;15(1):42-62.
68. Monafo WW. Tangential excision. Clin Plast Surg 1974;1(4):591-601.
69. Rosenberg L, Lapid O, Bogdanov-Berezovsky A, Glesinger R, Krieger Y, Silberstein E, Sagi A, Judkins K, Singer AJ. Safety and efficacy of a proteolytic enzyme for enzymatic burn debridement: a preliminary report. Burns 2004;30(8): 843-50.
70. Levenson S. Supportive therapy in burn care. Debriding agents. J Trauma 1979;19(11 Suppl): 928-30.
71. Jackson D, Topley W, Cason JS, Lowburry EJL. Primary excision and grafting of large burns. Ann. Surg 1969;167:152-7.
72. Hermans RP. De techniek van de behandeling van brandwonden. Leiden: Staphleu's wetenschappelijke uitgeversmaatschappy, 1968.
73. Herndon DN, Barrow RE, Rutan RL, Rutan TC, Desai MH, Abston S. A comparison of conservative versus early excision. Therapies in severely burned patients. Ann Surg 1989;209(5):547-52 (discussion 552-3).
74. Tanner JC Jr, Vandeput J, Olley JF. The Mesh Skin Graft. Plast Reconstr Surg 1964;34:287-92.
75. Vandeput J, Melissen M, Tanner JC, Boswick J. A review of skin meshers. Burns 1995;21(5): 364-70.
76. Vandeput JJ, Tanner JC, Boswick J. implementation of parameters in the expansion ratio of mesh skin grafts. Plast Reconstr Surg 1997;100(3): 653-6.
77. Meek CP. Microdermagrafting: the Meek technic. Hosp Top 1965;43:114-6.
78. Kreis RW, Mackie DP, Hermans RR, Vloemans AR. Expansion techniques for skin grafts: comparison between mesh and Meek island (sandwich-) grafts. Burns 1994;20 Suppl 1:539-42.
79. Kreis RW, Mackie DP, Vloemans AW, Hermans RP, Hoekstra MJ. Widely expanded postage stamp skin grafts using a modified Meek technique in combination with an allograft overlay. Burns 1993;19(2):142-5.
80. Lari AR, Gang RK. Expansion technique for skin grafts (Meek technique) in treatment severely burned patients. Burns 2001;27(1):61-6.
81. Kilic A, Ozdengil E. Skin graft fixation by applying cyanoacrylate without any complication. Plast Reconstr Surg 2002;110(1):370-1.
82. Buckley RC, Breazeale EE, Edmond JA, Brzezienski MA. A simple preparation of autologous fibrin glue for skin-graft fixation. Plast Reconstr Surg 1999;103(1):202-6.
83. Davey RB, Sparnon AL, Lodge M. Technique of split skin graft fixation using hypafix: a 15-year review. ANZ J Surg 2003;73(11):958-62.
84. Kreis RW, Vloemans AF. Fixation of skin transplants in burns with SurfaSoft and staples. An analysis of the results. Scand J Plast Reconstr Surg Hand Surg 1987;21(3):249-51.
85. Vloemans AF, Kreis RW. Fixation of skin grafts with a new silicone rubber dressing (mepitel). Scand J Plast Reconstr Surg Hand Surg 1994;28(1):75-6.
86. Isago T, Nozaki M, Kikuchi Y, Honda T, Nakazawa H. Skin graft fixation with negative-pressure dressings. J Dermatol 2003;30(9):673-8.
87. Scherer LA, Shiver S, Chang M, Meredith JW, Owings JT. The vacuum assisted closure device: a method of securing skin grafts and improving graft survival. Arch Surg 2002;137(8):930-3 (discussion 933-4).
88. Gallico GG III, O'Connor NE. Cultured epithelium as a skin substitute. Clin Plast Surg 1985;12(2):149-57.
89. Gallico GG III, O'Connor NE, Compton CC, Kehinde O, Green H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 1984;311(7): 448-51.
90. Teepe RG, Ponec M, Kreis RW, Hermans RP. Improved grafting method for treatment of burns with autologous cultured human epithelium [letter]. Lancet 1986;1(8477):385.
91. Boyce ST, Warden GD, Holder IA. Cytotoxicity testing of topical antimicrobial agents on human keratinocytes and fibroblasts for cultured skin grafts. J Burn Care Rehabil 1995;16(2 pt 1):97-103.
92. Phillips TJ, Gilchrest BA. Clinical applications of cultured epithelium. Epithelial Cell Biol 1992;1(1):39-46.
93. Sheridan RL, Tompkins RG. Recent clinical experience with cultured autologous epithelium. Br J Plast Surg 1996;49(1):72-4.
94. Sheridan RL, Tompkins RG. Cultured autologous epithelium in patients with burns of ninety percent or more of the body surface. J Trauma 1995;38(1):48-50.
95. Kreis RW, Hoekstra MJ, Mackie DP, Vloemans AF, Hermans RP. Historical appraisal of the use of skin allografts in the treatment of extensive full skin thickness burns at the Red Cross Hospital Burns Centre, Beverwijk, The Netherlands. Burns 1992;18 Suppl 2:S19-22.
96. Kreis RW, Vloemans AF, Hoekstra MJ, Mackie DP, Hermans RP. The use of non-viable glycerol-preserved cadaver skin combined with widely expanded autografts in the treatment of extensive third-degree burns. J Trauma 1989;29(1): 51-4.
97. Alsbjorn BF. Clinical results of grafting burns with epidermal Langerhans' cell depleted allograft overlay. Scand J Plast Reconstr Surg Hand Surg 1991;25(1):35-9.
98. Leicht P, Muchardt O, Jensen M, Alsbjorn BA, Sorensen B. Allograft vs. exposure in the treatment of scalds - a prospective randomized controlled clinical study. Burns Incl Therm Inj 1989;15(1):1-3.
99. Eldad A, Din A, Weinberg A, Neuman A, Lipton H, Ben-Bassat H, Chaouat M, Wexler MR. Cryopreserved cadaveric allografts for treatment of unexcised partial thickness flame burns: clinical experience with 12 patients. Burns 1997;23(7-8): 608-14.
100. Rose JK, Desai MH, Mlakar JM, Herndon DN. Allograft is superior to topical antimicrobial therapy in the treatment of partial-thickness scald burns in children. J Burn Care Rehabil 1997;18(4):338-41.
101. Gajiwala K, Gajiwala AL. Evaluation of lyophilised, gamma-irradiated amnion as a biological dressing. Cell Tissue Bank 2004;5(2):73-80.
102. Ravishanker R, Bath AS, Roy R. "Amnion Bank" - the use of long term glycerol preserved amniotic membranes in the management of superficial and superficial partial thickness burns. Burns 2003;29(4):369-74.
103. Maral T, Borman H, Arslan H, Demirhan B, Akinbingol G, Haberal M. Effectiveness of human amnion preserved long-term in glycerol as a temporary biological dressing. Burns 1999;25(7):625-35.
104. Chang CJ, Yang JY. Frozen preservation of human amnion and its use as a burn wound dressing. Changgeng Yi Xue Za Zhi 1994;17(4):316-24.
105. Dahinterova J, Dobrkovsky M. Treatment of the burned surface by amnion and chorion grafts. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove 1969 (Suppl):513-5.
106. Chiu T, Pang P, Ying SY, Burd A. Porcine skin: friend or foe? Burns 2004;30(7):739-41.
107. Hassan Z, Shah M. Porcine xenograft dressing for facial burns: meshed versus non-meshed. Burns 2004;30(7):753.
108. Mis B, Rolland E, Ronfard V. Combined use of a collagen-based dermal substitute and a fibrin-based cultured epithelium: a step toward a total skin replacement for acute wounds. Burns 2004;30(7):713-9.
109. Heitland A, Piatkowski A, Noah EM, Pallua N. Update on the use of collagen/glycosaminoglycate skin substitute-six years of experiences with artificial skin in 15 German burn centers. Burns 2004;30(5):471-5.
110. Ozerdem OR, Wolfe SA, Marshall D. Use of skin substitutes in pediatric patients. J Craniofac Surg 2003;14(4):517-20.
111. Wisser D, Steifes J. Skin replacement with a collagen based dermal substitute, autologous keratinocytes and fibroblasts in burn trauma. Burns 2003;29(4):375-80.
112. Barret JP, Dziewulski P, Wolf SE, Desai MH, Herndon DN. Outcome of scalp donor sites in 450 consecutive pediatric burn patients. Plast Reconstr Surg 1999;103(4):1139-42.
113. Madden MR, Nolan E, Finkelstein JL, Yurt RW, Smeland J, Goodwin CW, Hefton J, Staiano-Coico L. Comparison of an occlusive and a semi-occlusive dressing and the effect of the wound exudate upon keratinocyte proliferation. J Trauma 1989;29(7):924-30 (discussion 930-1).
114. Zapata-Sirvent R, Hansbrough JF, Carroll W, Johnson R, Wakimoto A. Comparison of biobrane and scarlet red dressings for treatment of donor site wounds. Arch Surg 1985;120(6): 743-5.
115. Innes ME, Umraw N, Fish JS, Gomez M, Cartotto RC. The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study. Burns 2001;27(6):621-7.
116. Hansbrough W. Nursing care of donor site wounds. J Burn Care Rehabil 1995;16(3 pt 1):337-9 (discussion 339-40).
117. Hyland WT. A painless donor-site dressing. Plast Reconstr Surg 1982;69(4):703-4.
118. Smith DJ Jr, Thomson PD, Garner WL, Rodriguez JL. Donor site repair. Am J Surg 1994;167(1A): 49S-51S.
119. Brezel BS, McGeever KE, Stein JM. Epinephrine v thrombin for split-thickness donor site hemostasis. J Burn Care Rehabil 1987;8(2):132-4.
120. Attwood AI. Calcium alginate dressing accelerates split skin graft donor site healing. Br J Plast Surg 1989;42(4):373-9.
121. Hermans MHE. Results of a survey on the use of different treatment options for partial and full thickness burns. Burns 1998;24(6):539-51.
122. Gear AJ, Hellewell TB, Wright HR, Mazzarese PM, Arnold PB, Rodeheaver GT, Edlich RF. A new silver sulfadiazine water soluble gel. Burns 1997;23(5):387-91.
123. Monafo WW, Ayvazian VH. Topical therapy. Surg Clin North Am 1978;58(6):1157-71.
124. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 2000;26(2):131-8.
125. Fox CL Jr. Silver sulfadiazine for control of burn wound infections. Int Surg 1975;60(5):275-7.
126. Barret JP, Dziewulski P, Ramzy PI, Wolf SE, Desai MH, Herndon DN. Biobrane versus 1% silver sulfadiazine in second-degree pediatric burns. Plast Reconstr Surg 2000;105(1):62-5.
127. Jarrett F, Ellerbe S, Demling R. Acute leukopenia during topical burn therapy with silver sulfadiazine. Am J Surg 1978;135(6):818-9.
128. Fraser GL, Beaulieu JT Leukopenia secondary to sulfadiazine silver. JAMA 1979;241(18):1928-9.
129. Caffee HH, Bingham HG. Leukopenia and silver sulfadiazine. J Trauma 1982;22(7):586-7.
130. Lockhart SP, Rushworth A, Azmy AA, Raine PA. Topical silver sulphadiazine: side effects and urinary excretion. Burns Incl Therm Inj 1983;10(1):9-12.
131. Gbaanador GB, Policastro AJ, Durfee D, Bleicher JN. Transient leukopenia associated with topical silver sulfadiazine in burn therapy. Nebr Med J 1987;72(3):83-5.
132. Choban PS, Marshall WJ. Leukopenia secondary to silver sulfadiazine: frequency, characteristics and clinical consequences. Am Surg 1987;53(9):515-7.
133. Eaglstein WH, Mertz PM, Falanga V. Occlusive dressings. Am Fam Physician 1987;35(3):211-6.
134. James JH, Watson AC. The use of opsite, a vapour permeable dressing, on skin graft donor sites. Br J Plast Surg 1975;28(2):107-10.
135. Harding KG, Jones V, Price P Topical treatment: which dressing to choose. Diabetes Metab Res Rev 2000;16 Suppl 1:S47-50.
136. Gotschall CS, Morrison MI, Eichelberger MR. Prospective, randomized study of the efficacy of mepitel on children with partial-thickness scalds. J Burn Care Rehabil 1998;19(4):279-83.
137. Benbow M, Iosson G. A clinical evaluation of urgotul to treat acute and chronic wounds. Br J Nurs 2004;13(2):105-9.
138. Meaume S, Senet P, Dumas R, Carsin H, Pannier M, Bohbot S. Urgotul: a novel non-adherent lipidocolloid dressing. Br J Nurs 2002;11 (16 Suppl): S42-3,S46-50.
139. Hermans MHE, Hutchinson JJ. Advantages of Occlusive Dressings. London: Springer Verlag, 1990.
140. Caruso DM, Foster KN, Hermans MH, Rick C. Aquacel Ag in the management of partial-thickness burns: results of a clinical trial. J Burn Care Rehabil 2004;25(1):89-97.
141. Kneafsey B, O'Shaughnessy M, Condon KC. The use of calcium alginate dressings in deep hand burns. Burns 1996;22(1):40-3.
142. Parsons D, Bowler PG, Walker M. Polishing the information on silver. Ostomy wound manage 2003;49(8):10-1 (author reply 11-2, 14, 16 passim).
143. Demling RH, DeSant L. Effects of silver on wound management. Wounds 2001;13(1):23-8.
144. Keswani MH, Patil AR. The boiled potato peel as a burn wound dressing: a preliminary report. Burns Incl Therm Inj 1985;11(3):220-4.
145. van Baare J, Ligtvoet EE, Middelkoop E. Microbiological evaluation of glycerolized cadaveric donor skin. Transplantation 1998;65(7): 966-70.
146. Noordenbos J, Dore C, Hansbrough JF. Safety and efficacy of transcyte for the treatment of partial-thickness burns, J Burn Care Rehabil 1999; 20(4):275-81.
147. Kumar RJ, Kimble RM, Boots R, Pegg SP. Treatment of partial-thickness burns: a prospective, randomized trial using transcyte. ANZ J Surg 2004;74(8):622-6.
148. Bello YM, Falabella AF, Eaglstein WH. Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol 2001;2(5):305-13.
149. Parente ST. Estimating the economic cost offsets of using dermagraft-TC as an alternative to cadaver allograft in the treatment of graftable burns. J Burn Care Rehabil 1997;18(1 pt 2):S18-24.
150. Hansbrough JF, Mozingo DW, Kealey GP, Davis M, Gidner A, Gentzkow GD. Clinical trials of a biosynthetic temporary skin replacement, dermagraft-transitional covering, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil 1997;18(1 pt 1):43-51.
151. Hansbrough J. Dermagraft-TC for partial-thickness burns: a clinical evaluation. J Burn Care Rehabil 1997;18(1 pt 2):S25-8.
152. Still J, Glat P, Silverstein P, Griswold J, Mozingo D. The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. Burns 2003;29(8):837-41.
153. Deitch EA, Wheelahan TM, Rose MP, Clothier J, Cotter J. Hypertrophic burn scars: analysis of variables. J Trauma 1983;23(10):895-8.
154. Worley CA. The wound healing process: part III - the finale. Dermatol Nurs 2004;16(3):274, 295.
155. Roques C. Pressure therapy to treat burn scars. Wound Repair Regen 2002;10(2):122-5.
156. Rochet JM, Zaoui A. [Burn scars: rehabilitation and skin care]. Rev Prat 2002;52(20):2258-63.
157. Puzey G. The use of pressure garments on hypertrophic scars. J Tissue Viability 2002;12(1):11-5.
158. Jordan RB, Daher J, Wasil K. Splints and scar management for acute and reconstructive burn care. Clin Plast Surg 2000;27(1):71-85.
159. Ayhan M, Gorgu M, Silistreli KO, Aytug Z, Erdogan B. Silastic sheet integrated polymethyl-metacrylate splint in addition to surgery for commissure contractures complicated with hypertrophic scar. Acta Chir Plast 2004;46(4): 132-5.
160. Van den Kerchhove E, Boeckx W, Kochuyt A. Silicone patches as a supplement for pressure therapy to control hypertrophic scarring. J Burn Care Rehabil 1991;12(4):361-9.
161. Kavanagh GM, Page P, Hanna MM. Silicone gel treatment of extensive hypertrophic scarring following toxic epidermal necrolysis. Br J Dermatol 1994;130(4):540-1.
162. Haedersdal M, Poulsen T, Wulf HC. Laser induced wounds and scarring modified by antiinflammatory drugs: a murine model. Lasers Surg Med 1993;13(1):55-61.
163. Beldon P. Management of scarring. J Wound Care 1999;8(10):509-12.
164. Lupton JR, Alster TS. Laser scar revision. Dermatol Clin 2002;20(1):55-65.
165. Liew SH, Murison M, Dickson WA. Prophylactic treatment of deep dermal burn scar to prevent hypertrophic scarring using the pulsed dye laser: a preliminary study. Ann Plast Surg 2002;49(5): 472-5.
166. Xiang J, Wang XQ, Qing C, Liao ZJ, Lu SL. [The influence of dermal template on the expressions of signal transduction protein Smad 3 and transforming growth factorbetal and its receptor during wound healing process in patients with deep burns]. Zhonghua Shao Shang Za Zhi 2005; 21(1)52-4.
167. Suliman MT. Experience with the seven flap-plasty for the release of burns contractures. Burns 2004;30(4):374-9.
168. Deb R, Giessler GA, Przybilski M, Erdmann D, Germann G. [Secondary plastic surgical reconstruction in severely burned patients], Chirurg 2004;75(6):588-98.
169. Lu KH, Guo SZ, Ai YF, Ma XJ. [Management of severe postburn scar contracture in the lower extremities], Zhonghua Shao Shang Za Zhi 2004;20(2):69-71.
170. Selezneva LG. Keloid scars after burns. Acta Chir Plast 1976;18(2):106-11.
171. Iudenich VV, Pal'tsyn AA, Zalugovskii OG. [Electron microscopic and autoradiographic study of keloid scars]. Arkh Patol 1982;44(1): 44-9.
172. Bang RL, Dashti H. Keloid and hypertrophic scars: trace element alteration. Nutrition 1995;11(5 Suppl)527-31.
173. Morison WL. Oral treatment of keloid. Med J Aust 1968;1(10):412-3.
174. Donati L, Taidelli Palmizi GA. [Treatment of hypertrophic and keloid cicatrices with thiomucase]. Minerva Chir 1975;30(6):326-33.
175. Tammelleo AD. Suit for post-operative scar: keloid or burn? Regan Rep Nurs Law 1996;37(4):4.
176. Ahlering PA. Topical silastic gel sheeting for treating and controlling hypertrophic and keloid scars: case study. Dermatol Nurs 1995;7(5): 295-7, 322.
177. Sizov VM. [The diagnosis and treatment of hypertrophic and keloid scars]. Klin Khir 1994;9:41-3.